{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:18:20Z","timestamp":1793254700500,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,26]],"date-time":"2012-02-26T00:00:00Z","timestamp":1330214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10549-012-1996-6","type":"journal-article","created":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T08:23:04Z","timestamp":1330158184000},"page":"387-391","source":"Crossref","is-referenced-by-count":58,"title":["Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)"],"prefix":"10.1007","volume":"133","author":[{"suffix":"Jr.","given":"Hatem A.","family":"Azim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Metzger-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine","family":"Focant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Gresko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounir","family":"Arfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart-Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,26]]},"reference":[{"issue":"16","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. New Engl J Med 353(16):1659\u20131672","journal-title":"New Engl J Med"},{"issue":"16","key":"1996_CR2","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl J Med 353(16):1673\u20131684","journal-title":"New Engl J Med"},{"issue":"14","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","volume":"365","author":"D Slamon","year":"2011","unstructured":"Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J (2011) Adjuvant trastuzumab in HER2-positive breast cancer. New Engl J Med 365(14):1273\u20131283","journal-title":"New Engl J Med"},{"issue":"4","key":"1996_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cncr.24835","volume":"116","author":"ME Abusief","year":"2010","unstructured":"Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH (2010) The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 116(4):791\u2013798","journal-title":"Cancer"},{"key":"1996_CR5","first-page":"1","volume":"21","author":"TJ Matthews","year":"2009","unstructured":"Matthews TJ, Hamilton BE (2009) Delayed childbearing: more women are having their first child later in life. NCHS Data Brief 21:1\u20138","journal-title":"NCHS Data Brief"},{"issue":"9","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1200\/JCO.2008.16.0309","volume":"26","author":"S Pant","year":"2008","unstructured":"Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL (2008) Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol 26(9):1567\u20131569","journal-title":"J Clin Oncol"},{"issue":"1","key":"1996_CR7","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.ajog.2009.02.017","volume":"201","author":"JM Beale","year":"2009","unstructured":"Beale JM, Tuohy J, McDowell SJ (2009) Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol 201(1):e13\u2013e14","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1470-2045(06)71014-2","volume":"8","author":"AA Bader","year":"2007","unstructured":"Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E (2007) Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 8(1):79\u201381","journal-title":"Lancet Oncol"},{"issue":"1","key":"1996_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/annonc\/mdm542","volume":"19","author":"ID Witzel","year":"2008","unstructured":"Witzel ID, Muller V, Harps E, Janicke F, Dewit M (2008) Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 19(1):191\u2013192","journal-title":"Ann Oncol"},{"issue":"6","key":"1996_CR10","first-page":"367","volume":"6","author":"HA Azim Jr","year":"2009","unstructured":"Azim HA Jr, Peccatori FA, Liptrott SJ, Catania C, Goldhirsch A (2009) Breast cancer and pregnancy: how safe is trastuzumab? Nat Rev 6(6):367\u2013370","journal-title":"Nat Rev"},{"issue":"6","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eci.10.77","volume":"6","author":"HA Azim Jr","year":"2010","unstructured":"Azim HA Jr, Azim H, Peccatori FA (2010) Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol 6(6):821\u2013826","journal-title":"Expert Rev Clin Immunol"},{"issue":"18","key":"1996_CR12","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","volume":"46","author":"F Amant","year":"2010","unstructured":"Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn HJ, Struikmans H, Christiaens MR, Cameron D, Du Bois A (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46(18):3158\u20133168","journal-title":"Eur J Cancer"},{"issue":"1","key":"1996_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejca.2010.09.007","volume":"47","author":"HA Azim Jr","year":"2011","unstructured":"Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, Peccatori FA (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47(1):74\u201383","journal-title":"Eur J Cancer"},{"issue":"2","key":"1996_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10549-011-1643-7","volume":"129","author":"O Pagani","year":"2011","unstructured":"Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A (2011) Pregnancy after breast cancer: if you wish, ma\u2019am. Breast Cancer Res Treat 129(2):309\u2013317","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"1996_CR15","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1371\/journal.pmed.0030336","volume":"3","author":"K Dalberg","year":"2006","unstructured":"Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer\u2014a population-based cohort study from Sweden. PLoS Med 3(9):e336","journal-title":"PLoS Med"},{"issue":"9555","key":"1996_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","volume":"369","author":"I Smith","year":"2007","unstructured":"Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sanchez Rovira P, Piccart-Gebhart MJ (2007) 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369(9555):29\u201336","journal-title":"Lancet"},{"issue":"3","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1470-2045(11)70033-X","volume":"12","author":"L Gianni","year":"2011","unstructured":"Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C, Cameron D, Mano M, Pedrini JL, Veronesi A, Mendiola C, Pluzanska A, Semiglazov V, Vrdoljak E, Eckart MJ, Shen Z, Skiadopoulos G, Procter M, Pritchard KI, Piccart-Gebhart MJ, Bell R (2011) Treatment with trastuzumab for 1\u00a0year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol 12(3):236\u2013244","journal-title":"Lancet Oncol"},{"issue":"25","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM198812223192501","volume":"319","author":"JL Mills","year":"1988","unstructured":"Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, Metzger B, Bieber FR, Knopp RH, Holmes LB et al (1988) Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21\u00a0days of conception. New Engl J Med 319(25):1617\u20131623","journal-title":"New Engl J Med"},{"key":"1996_CR19","first-page":"987","volume":"34","author":"S Daniels","year":"2011","unstructured":"Daniels S, Johnston M, Hiles L (2011) Herceptin (trastuzumab) and the incidence of spontaneous abortion. Drug Saf 34:987","journal-title":"Drug Saf"},{"issue":"2","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ctrv.2009.11.007","volume":"36","author":"HA Azim Jr","year":"2010","unstructured":"Azim HA Jr, Peccatori FA, Pavlidis N (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: solid tumors. Cancer Treat Rev 36(2):101\u2013109","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/bdrb.20201","volume":"86","author":"N Pentsuk","year":"2009","unstructured":"Pentsuk N, van der Laan JW (2009) An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res 86(4):328\u2013344","journal-title":"Birth Defects Res"},{"issue":"24","key":"1996_CR22","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1016\/S0264-410X(03)00333-5","volume":"21","author":"A Malek","year":"2003","unstructured":"Malek A (2003) Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 21(24):3362\u20133364","journal-title":"Vaccine"},{"issue":"2","key":"1996_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11523-009-0112-2","volume":"4","author":"E Azambuja de","year":"2009","unstructured":"de Azambuja E, Bedard PL, Suter T, Piccart-Gebhart M (2009) Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Target Oncol 4(2):77\u201388","journal-title":"Target Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-1996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-1996-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-1996-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-1996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T20:03:17Z","timestamp":1581969797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-1996-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-1996-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,26]]}}}